Salah Mohamed El Sayed. Oxidative Stress Therapy for Cancer Using Glycolysis Inhibitors: Towards Improving Therapeutic Outcomes.
. 2018; 6(1):11-15. doi: 10.12691/AJMBR-6-1-3
3-bromopyruvate, EPR effect, PEG formulation, glycolysis, citrate
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | Baghdadi HH. Targeting Cancer Cells using 3‑bromopyruvate for Selective Cancer Treatment. Saudi J Med Med Sci 2017; 5: 9-19. |
|
[2] | Pervaiz, S., Clement, M. V. (2004). Tumor intracellular redox status and drug resistance - serendipity or a causal relationship? Current Pharmacological Design 10(16), 1969-1977. |
|
[3] | Tiligada, E. Chemotherapy: induction of stress responses. (2006). Endocrine-related cancer, 13 Suppl. 1), S115-S124. |
|
[4] | Sullivan, R., Graham, C. H. (2008). Chemosensitization of cancer by nitric oxide. Current Pharmaceutical Design, 14, 1113-1123. |
|
[5] | Schneider, B. L., Kulesz-Martin, M. (2004). Destructive cycles: the role of genomic instability and adaptation in carcinogenesis. Carcinogenesis, 25, 2033-2044. |
|
[6] | Martinez-Sanchez, G., Giuliani, A. (2007). Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumor development. Journal of Experimental & Clinical Cancer Research, 26, 39-50. |
|
[7] | Chen, E.I., Hewel, J., Krueger, J.S., Tiraby, C., Weber, M.R., Kralli, A., et al. (2007). Adaptation of energy metabolism in breast cancer brain metastases. Cancer Research, 67(4), 1472-1486. |
|
[8] | Hara, E., Takahashi, K., Takeda, K., Nakayama, M., Yoshizawa, M., Fujita, H. et al. (1999). Induction of heme oxygenase-1 as a response in sensing the signals evoked by distinct nitric oxide donors. Biochemical Pharmacology, 58, 227-236. |
|
[9] | Hartsfield, S.L,, Alam, J., Cook, J.L., Choi, AM. (1997). Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. The American Journal of Physiology, 273, 980-988. |
|
[10] | Doi, K., Akaike, T., Fujii, S., Tanaka, S., Ikebe, N., Beppu, T. et al. (1999). Induction of heme oxygenase-1 by nitric oxide and ischaemia in experimental solid tumors and implications for tumor growth. British Journal of Cancer, 80, 1945-1954. |
|
[11] | Maines, M.D., Abrahamsson, P.A. (1996). Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology, 47, 727-74733. |
|
[12] | Hara, E., Takahashi, K., Tominaga, T., Kumabe, T., Kayama, T., Suzuki, H. et al. (1996). Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochemical and Biophysical Research Communications, 224, 153-158. |
|
[13] | Goodman, A.I., Choudhury, M., da Silva, J.L., Schwartzman, M.L., Abraham, N.G. (1997). Overexpression of the heme oxygenase gene in renal cell carcinoma. Proceedings of The Society of Experimental Biology and Medicine, 214, 54-61. |
|
[14] | Tsutsumishita, Y., Onda, T., Okada, K., Takeda, M., Endou, H., Futaki, S. et al (1998). Involvement of H2O2 production in cisplatin-induced nephrotoxicity. Biochemical and Biophysical Research Communications, 242(2), 310-312. |
|
[15] | Sawa, T., Wu, J., Akaike, T., Maeda, H. (2000). Tumor-targeting chemotherapy by a xanthine oxidase–polymer conjugate that generates oxygen-free radicals in tumor tissue, Cancer Research, 60, 666-671. |
|
[16] | Tsutsumi, Y., Kihara, T., Yamamoto, S., Kubo, K., Nakagawa, S., Miyake, M., et al. (1994). Chemical modification of natural human tumor necrosis factor-alpha with polyethylene glycol increases its antitumor potency. Japanese Journal of Cancer Research, 85, 9-12. |
|
[17] | Fang, J., Sawa, T., Akaike, T., Maeda, H. (2002).Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide. Cancer Research, 62(11), 3138-3143. |
|
[18] | Matsumura, Y., and Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Research, 46, 6387-6392. |
|
[19] | Doi, K., Akaike, T., Fujii, S., Tanaka, S., Ikebe N., Beppu, T. et al. (1999). Induction of heme oxygenase-1 nitric oxide and ischaemia in experimental solid tumors and implications for tumour growth. British Journal of Cancer, 80(12), 1945-1954. |
|
[20] | Sahoo, S.K., Sawa, T., Fang, J., Tanaka, S., Miyamoto, Y., Akaike, T. et al. (2002). Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity. Bioconjugate Chemistry, 13(5), 1031-1038. |
|
[21] | Fang, J., Sawa, T., Akaike, T., Greish, K., Maeda, H. (2004). Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. International Journal of Cancer. 109(1), 1-8. |
|
[22] | El Sayed, S.M., Abou El-Magd, R.M., Shishido, Y., Chung, S.P., Sakai, T., Watanabe, H., et al. (2012). D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate. Cancer Gene Therapy, 19, 1-18. |
|
[23] | El Sayed, S.M., Abou El-Magd, R.M., Shishido, Y., Chung, S.P., Diem, T.H., Sakai, T., et al. (2012). 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects. Journal of bioenergetics and biomembranes. 2012 Feb; 44(1) :61-79.. |
|
[24] | Chung, S.P., Sogabe, K., Park, H.K., Song, Y., Ono, K., Abou El-Magd, R.M., et al. (2010). Potential cytotoxic effect of hydroxypyruvate produced from D-serine by astroglial D-amino acid oxidase. Journal of Biochemistry, 148(6), 743-753. |
|
[25] | Zhang, W.B., Wang, Z., Shu, F., Jin, Y.H., Liu, H.Y., Wang, Q.J., et al. (2010). Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. The Journal of Biological Chemistry, 285, 40461-40471. |
|
[26] | Neman, J., Jandial, R. (2010). Decreasing glioma recurrence through adjuvant cancer stem cell inhibition. Biologics, 4, 157-162. |
|
[27] | Colen, C.B., Shen, Y., Ghoddoussi, F., Yu, P., Francis, T.B., Koch, B.J., et al. (2011). Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study, Neoplasia, 13(7), 620-632. |
|
[28] | Mulet, C., Lederer, F. (1977). Bromopyruvate as an affinity label for baker's yeast flavocytochrome b2. Kinetic study of the inactivation reaction. European Journal of Biochemistry, 73(2), 443-447. |
|
[29] | Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., et al. (2007). Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood, 109(9), 3812-3819. |
|
[30] | Heindel, J.J., Bates, H.K., Price, C.J., Marr, M.C., Myers, C.B., Schwetz, B..A. (1996). Developmental toxicity evaluation of sodium fluoride administered to rats and rabbits in drinking water. Fundamental and Applied Toxicology, 30(2):162-177. |
|
[31] | Newby, C.S., Rowland, J.L., Lynch, R.J., Bradshaw, D.J., Whitworth, D., Bosma M.L. (2011). Benefits of a silica-based fluoride toothpaste containing o-cymen-5-ol, zinc chloride and sodium fluoride. International Dental Journal, Suppl 3, 74-80. |
|
[32] | Black, M.M., Kleiner, I.S., Bolker, H. (1949). Glycolytic enzyme inhibitor therapy in human malignant neoplasia. Cancer Research, 9(5), 314-319. |
|
[33] | Bertrand, R., O'Connor, P.M., Kerrigan, D., Pommier Y. (1992). Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells. European Journal of Cancer, 28A(4-5),743-748. |
|
[34] | Ko, Y.H., Pedersen, P.L., Geschwind, J.F. (2001). Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Letters, 173(1), 83-91. |
|
[35] | Ko, Y.H., Smith, B.L., Wang, Y., Pomper, M.G., Rini, D.A., Torbenson, M.S., et al. (2004). Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochemical and Biophysical Research Communication, 324(1), 269-275. |
|
[36] | Ihrlund, L.S., Hernlund, E., Khan, O., Shoshan, M.C. (2008). 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs. Molecular Oncology, 2(1), 94-101. |
|
[37] | Bhardwaj, V., Rizvi, N., Lai, M.B., Lai, J.C., Bhushan, A. (2010). Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics. Anticancer Research, 30(3), 743-749. |
|
[38] | Leary, S.C., Hill, B.C., Lyons, C.N., Carlson, C.G., Michaud, D., Kraft, C.S., et al. (2002). Chronic treatment with azide in situ leads to an irreversible loss of cytochrome c oxidase activity via holoenzyme dissociation. The Journal of Biological Chemistry, 277(13), 11321-11328. |
|
[39] | Morland, C., Boldingh, K.A., Iversen, E.G., Hassel, B. (2004). Valproate is neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake. Journal of Cerebral Blood Flow and Metabolism, 24(11), 1226-1234. |
|